Home Economy Entrepreneurship Renowned vaccine researcher Dr. Anne S. De Groot is ready to take...

Renowned vaccine researcher Dr. Anne S. De Groot is ready to take on cancer but can she find workers to keep up with everything else?

By Kaylen Auer

FAST SEQUENCING: Dr. Anne S. De Groot, EpiVax Inc. CEO and chief strategy officer, says the Providence company has spent the past 20 years developing immunoinformatics tools. EpiVax spinoff EpiVax Oncology will use those tools along with fast sequencing to design cancer vaccines specific to individual patients. / PBN PHOTO/MICHAEL SALERNO
FAST SEQUENCING: Dr. Anne S. De Groot, EpiVax Inc. CEO and chief strategy officer, says the Providence company has spent the past 20 years developing immunoinformatics tools. EpiVax spinoff EpiVax Oncology will use those tools along with fast sequencing to design cancer vaccines specific to individual patients. / PBN PHOTO/MICHAEL SALERNO

In 1997, Dr. Anne S. De Groot founded EpiVax Inc. in ­Providence, backed by a Small Business Innovation Research grant from the National Institutes of Health and a little state funding. Two decades later, De Groot is as an internationally lauded researcher and a respected leader in the local biotech and academic scene. And EpiVax

Already a Subscriber? Log in

To Continue Reading This Article

Become a Providence Business News subscriber and get immediate access to all of our premier content and much more.

Learn More and Become a Subscriber

NO COMMENTS

Exit mobile version